Posts by ericg

Some of the largest Boston-area biotech and pharmaceutical companies are still hoping to net drug approvals from the FDA by the end of 2023. Read More

To address the long-term needs of the industry, we must inspire and equip the next generation of talent by fostering K-12 STEM education in high-need communities, writes Sunny Schwartz of the Massachusetts Biotechnology Education Foundation. Read More

Workplaces need to think proactively about how to support women who are both breadwinners and primary caretakers, or else they may lose out on leadership opportunities. Read More

Millennium Partners founder Christopher Jeffries spoke with the Business Journal about leasing in the Boston office tower — "a lot of activity in the building," but "we’d like to have been further ahead than we are" — and whether its future office towers will also feature passive house design. Read More

Massachusetts’ fastest growing company might not exist if Siyana and Andy Huszar didn’t meet on a blind date in 2012. The pair went on to co-found Marcella, an ethical women’s fashion brand. Read More

A blood plasma-testing company born out at the Dana-Farber Cancer Institute is launching with $57 million and a plan to speed up precision medicine. Read More

Finally, some big funding rounds in 2023! By our count, Boston-area companies raised $1.7 billion in September. Read about all the deals. Read More

Here are the five things you need to know in Boston business news to start your Thursday, plus fat bears, cannabis job losses and the Boston connection to Banned Books Week. Read More

Also, almost two years after it agreed to buy Lexington-based Dicerna Pharmaceuticals Inc. for $3.3 billion, Novo Nordisk has scored its first drug approval from the acquisition. Here’s news from the life sciences you may have missed. Read More

GreenCare Collective is being sued by Renovation Capital over claims that the cannabis company failed to make loan payments and misled investors. Read More